Legal · Clinical

Clinical Safety & Disclaimer

Last Updated: August 2025
Important: prajnaScan is a clinical decision support tool. It is not a diagnostic device and does not replace the judgment of a licensed medical professional. All AI outputs must be reviewed by a qualified physician before any clinical action is taken.

1. Intended Use

prajnaScan is designed as a clinical workflow support tool for use by licensed healthcare professionals in outpatient clinical settings. Its intended functions are:

prajnaScan is not intended for patient self-diagnosis. Raw AI outputs are never delivered directly to patients — only clinician-reviewed and approved summaries may be shared with patients at the physician's discretion.

Current scope: symptom triage and structured patient history. Multimodal health assessments (camera or sensor inputs) are not yet part of the product and will be introduced only after independent clinical validation.


2. Clinical Oversight

Every AI-generated output from prajnaScan — including triage scores, red-flag alerts, and pre-diagnosis notes — is subject to the following oversight requirements:


3. Accuracy & Limitations

Current Capabilities

prajnaScan's triage engine operates on structured symptom questionnaires and rule-based clinical logic, augmented by ML-derived urgency scoring. It is validated against primary care presentations in Tier 2 & 3 clinic settings.

Known Limitations

Confidence Thresholds & Escalation

The system flags outputs with a confidence score. Low-confidence outputs trigger explicit escalation notices in the doctor view, indicating that additional clinical assessment is required before acting on the AI suggestion.


4. Patient Safety Commitments


5. Regulatory Status

prajnaScan currently operates as a clinical decision support software tool and does not fall within the definition of a Class B or higher medical device under the Medical Devices Rules 2017 (India). It functions as a software workflow aid that presents information to a licensed physician — all clinical decisions remain with the physician.

As prajnaScan's capabilities expand (including potential multimodal assessments), we will proactively evaluate applicable regulatory pathways with India's Central Drugs Standard Control Organisation (CDSCO) and pursue any required approvals before launching new diagnostic-adjacent features.


6. Disclaimer

prajnaScan is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of information generated by prajnaScan.

AlakhAgam India Pvt. Ltd. is not liable for clinical outcomes arising from:


7. Contact

For clinical safety inquiries, adverse event reporting, or questions about our validation protocols:

AlakhAgam India Pvt. Ltd. — Clinical Safety
Email: clinical@alakhagam.com
Website: www.alakhagam.com